CDKN2A and meningioma: When we plotted the CDKN2A mRNA expression levels of CDKN2A intact/wt meningiomas based on each sample’s IHC score, we found that tumors with “3+” or diffuse p16 positivity on IHC had significantly higher CDKN2A mRNA expression compared to all other groups (Fig. 5m).